您的位置: 首页 > 2022年1月 第52卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

两种常用免疫学指标对结核病的辅助诊断价值

The auxiliary diagnostic value of two common immunological indicators for tuberculosis

来源期刊: 广州医药 | 50-53 发布时间:2022-04-12 收稿时间:2025/11/13 18:26:12 阅读量:11
作者:
关键词:
结核病TB-IGRA结核菌素试验辅助诊断
tuberculosisTB-IGRAPPD testauxiliary diagnosis
DOI:
10.3969/j.issn.1000-8535.2022.01.010
收稿时间:
2021-08-21 
修订日期:
 
接收日期:
 
引用总数:
1  
目的 探索两种常用免疫学指标—结核菌素试验(purified protein derivative skin test, PPD皮试)与结核分枝杆菌γ-干扰素释放试验(tuberculosis-interferon gamma release assay,TB-IGRA)对结核病的辅助诊断价值。方法 收集2017年1月—2021年1月于我中心门诊部就诊的疑似结核病患者资料,共171例,所有病例均行PPD皮试和外周血TB-IGRA。将病例分为结核病组(TB组)和非结核病组(非TB组)。TB组共98例,非TB组共73例。比较两组病例PPD皮试、TB-IGRA对结核病诊断的准确度、敏感度、特异度。结果 TB-IGRA对结核病诊断的准确度、敏感度和特异度分别为94.2%、93.9%和90.4%,PPD皮试对结核病诊断的准确度、敏感度和特异度分别为77.2%、84.7%和76.7%。TB-IGRA的准确度和特异度与PPD皮试比较差异有统计学意义(分别为χ2=20.034,P<0.05和χ2=5.176,P<0.05);TB-IGRA的敏感度高于PPD皮试,但两者比较差异无统计学意义(χ2=0.948,P>0.05)。2组间TB-IGRA结果、PPD皮试结果比较差异均具有统计学意义(分别为χ2=132.77,P<0.01和χ2=47.963 5,P<0.01)。结论 TB-IGRA和PPD皮试均具有良好的结核病辅助诊断价值;TB-IGRA的引进大大提高了诊断试验的准确度和特异度,但仍需要进一步探索其诊断标准以更好地为临床使用。
Objective To explore the auxiliary diagnosis value of two commonly used immunological indicators for tuberculosis, purified protein derivative skin test (PPD test) and tuberculosis-interferon gamma release assay (TB-IGRA). Methods A total of 171 cases of suspected tuberculosis patients who were treated in the outpatient department of our center from January 2017 to January 2021 were collected. All cases underwent PPD test and peripheral blood TB-IGRA. The cases were divided into tuberculosis groups (TB group) and non-tuberculosis group (non-TB group). There were 98 cases in the TB group and 73 cases in the non-TB group. The accuracy, sensitivity, and specificity of PPD test and TB-IGRA for tuberculosis diagnosis were compared between the two groups. Results The accuracy, sensitivity, and specificity of TB-IGRA for tuberculosis diagnosis were 94.2%, 93.9% and 90.4% respectively, which of PPD test for tuberculosis diagnosis were 77.2%, 84.7% and 76.7% respectively. The accuracy and specificity of TB-IGRA were statistically different from those of PPD test (χ2=20.034,P<0.05 and χ2=5.176,P<0.05, respectively). The sensitivity of TB-IGRA was higher than that of PPD test, but the difference was not statistically significant (χ2=0.948,P>0.05). The differences of TB-IGRA and PPD test results between the two groups were statistically significant (χ2=132.77,P<0.01 and χ2=47.9635,P<0.01). Conclusion Both TB-IGRA and PPD test had good auxiliary diagnostic value for tuberculosis; the introduction of TB-IGRA had greatly improved the accuracy and specificity of the diagnostic test, but it is still necessary to further explore its diagnostic criteria to better serve the clinical use.
1、 OH C E, ORTIZ-BRIZUELA E, BASTOS M L,et al. Comparing the diagnostic performance of QFT-Plus to other tests of latent tuberculosis infection:a systematic review and meta-analysis[J].Clin Infect Dis,2021,73(5):e1116-e1125. OH C E, ORTIZ-BRIZUELA E, BASTOS M L,et al. Comparing the diagnostic performance of QFT-Plus to other tests of latent tuberculosis infection:a systematic review and meta-analysis[J].Clin Infect Dis,2021,73(5):e1116-e1125.
2、 吴晓康,周维肖,冯楠,等.影响TB-IGRA检测结果的因素分析及应对措施[J].现代检验医学杂志,2018,33(4):154-156. 吴晓康,周维肖,冯楠,等.影响TB-IGRA检测结果的因素分析及应对措施[J].现代检验医学杂志,2018,33(4):154-156.
3、 WALSH M C,CAMERLIN A J,MILES R,et al. The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes[J].Int J Tuberc Lung Dis,2011,15(2):179-84,i-iii. WALSH M C,CAMERLIN A J,MILES R,et al. The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes[J].Int J Tuberc Lung Dis,2011,15(2):179-84,i-iii.
4、 KWON Y S,KIM Y H,JEON K,et al. Factors that predict negative results of QuantiFERON-TB Gold In-Tube test in patients with culture-confirmed tuberculosis:a multicenter retrospective cohort study[J].PLoS One,2015,10(6): e0129792. KWON Y S,KIM Y H,JEON K,et al. Factors that predict negative results of QuantiFERON-TB Gold In-Tube test in patients with culture-confirmed tuberculosis:a multicenter retrospective cohort study[J].PLoS One,2015,10(6): e0129792.
5、 SHINGADIA D, NOVELLI V.The tuberculin skin test:a hundred,not out?[J].Arch Dis Child,2008(93):189-190. SHINGADIA D, NOVELLI V.The tuberculin skin test:a hundred,not out?[J].Arch Dis Child,2008(93):189-190.
6、 FARHAT M, GREENAWAY C, PAI M, MENZIES D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?[J]. Int J Tuberc Lung Dis,2006,10(11):1192-1204. FARHAT M, GREENAWAY C, PAI M, MENZIES D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?[J]. Int J Tuberc Lung Dis,2006,10(11):1192-1204.
7、 国务院办公厅.国务院办公厅关于印发“十三五”全国结核病防治规划的通知[EB/OL].(2017-02-01)[2021-08-21]http://www.gov.cn/zhengce/content/2017-02/16/content_5168491.htm. 国务院办公厅.国务院办公厅关于印发“十三五”全国结核病防治规划的通知[EB/OL].(2017-02-01)[2021-08-21]http://www.gov.cn/zhengce/content/2017-02/16/content_5168491.htm.
8、 杨帆,胡良安.肺结核分子诊断方法研究进展[J].现代医药卫生,2020,36(22):3593-3597. 杨帆,胡良安.肺结核分子诊断方法研究进展[J].现代医药卫生,2020,36(22):3593-3597.
9、 BOEHME C C.Rapid molecular detection of tuberculosis and rifampin resistance[J].N Engl J Med,2010,363(11):1005-1015. BOEHME C C.Rapid molecular detection of tuberculosis and rifampin resistance[J].N Engl J Med,2010,363(11):1005-1015.
10、 FORBES B A,HALL G S,MILLER M B,et al. Practice guidelines for clinical microbiology laboratories: mycobacteria[J].Clin Microbiol Rev,2018,31(2):e00038-17. FORBES B A,HALL G S,MILLER M B,et al. Practice guidelines for clinical microbiology laboratories: mycobacteria[J].Clin Microbiol Rev,2018,31(2):e00038-17.
11、 RYU Y J. Diagnosis of pulmonary tuberculosis: recent advances and diagnostic algorithms[J].Tuberc Respir Dis(Seoul),2015,78(2):64-71. RYU Y J. Diagnosis of pulmonary tuberculosis: recent advances and diagnostic algorithms[J].Tuberc Respir Dis(Seoul),2015,78(2):64-71.
12、 张梅,焦祖伟,聂渝琼.我国结核病诊断方法现状与进展[J].中国卫生检验杂志,2011.21(12):3018-3020. 张梅,焦祖伟,聂渝琼.我国结核病诊断方法现状与进展[J].中国卫生检验杂志,2011.21(12):3018-3020.
13、 姚篙,方雪晖.《中国结核病预防控制工作技术规范(2020年版)》[J].热带病与寄生虫学,2020,18(3):138-141. 姚篙,方雪晖.《中国结核病预防控制工作技术规范(2020年版)》[J].热带病与寄生虫学,2020,18(3):138-141.
14、 中华人民共和国国家卫生和计划生育委员会.中华人民共和国卫生行业标准-肺结核诊断(WS 288-2017)[S].新发传染病电子杂志,2018,3(1):59-61. 中华人民共和国国家卫生和计划生育委员会.中华人民共和国卫生行业标准-肺结核诊断(WS 288-2017)[S].新发传染病电子杂志,2018,3(1):59-61.
15、 WHO.GLOBAL TUBERCULOSIS REPORT 2020[R/OL].(2020-10-15)[2021-08-21]https://www.who.int/publications/i/item/9789240013131. WHO.GLOBAL TUBERCULOSIS REPORT 2020[R/OL].(2020-10-15)[2021-08-21]https://www.who.int/publications/i/item/9789240013131.
1、郭慧莲,郑圣坤,陈志颖,等.外周血CD4+细胞数正常的结核性脑膜炎患儿血IGRAs与TST比较分析[J].系统医学,2022,7(24):157-160.DOI:10.19368/j.cnki.2096-1782.2022.24.157. 郭慧莲,郑圣坤,陈志颖,等.外周血CD4+细胞数正常的结核性脑膜炎患儿血IGRAs与TST比较分析[J].系统医学,2022,7(24):157-160.DOI:10.19368/j.cnki.2096-1782.2022.24.157.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录